Bernard Davitian
@bernarddavitian
Director
Building Lysosomal Therapeutics, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Lysosomal Therapeutics, Inc. was founded in 2011 and has no closure on record.
Named alongside
At Endeavor Biomedicines, Inc.
- Chris KruegerExecutive Officer
- Enoch KariukiExecutive Officer
- John HoodDirector, Executive Officer
- Karan Cheong TakharDirector
- Miguel de los RiosExecutive Officer
- Monal Cheong MehtaDirector
- Patrick G. EnrightDirector
- Raghu SaripalliExecutive Officer
At Lysosomal Therapeutics, Inc.
- Bruce BoothDirector
- Bruce L BoothDirector
- Carole E. NuechterleinDirector
- Carole NeuchterleinDirector
- Carole NuechterleinDirector
- Clay E. ThorpDirector
- Clay ThorpDirector
- Cornelis BeenExecutive Officer, Director
- James SullivanChief Executive Officer and Director
- Jonathan SilversteinPresident & Director
- MONA ASHIYADirector
- Rand SutherlandDirector
- Sara NayeemDirector
- Stephen SquintoDirector
- Uya ChuluunbaatarDirector
- Viola MeehanExecutive Officer
Contribution
Bernard's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Lysosomal Therapeutics, Inc.Director · Biotechnology · CAMBRIDGE, United States · Founded 2011
- SURMOUNT BIO, INC.formerly SURMOUNT BIO, INC.; filing with the SEC since 2019Director · Other Technology · CHICAGO, United States · Founded 2019
- Endeavor Biomedicines, Inc.Director · Biotechnology · San Diego, United States · Founded 2018